Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-24

Clinical Trial Update: Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metoclopramide in combination with ketoprofen for acute migraine in children was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoprofen (Ketoprofen)
  • Metoclopramide (metoclopramide)

Snippet

Sponsor: IRCCS Burlo Garofolo | Conditions: Migraine | Phase 3 | Status: WITHDRAWN